Aisling Capital Management’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.6M	Buy	1,555,664 +83,333	+6%	+$1.59M	5.37%	3
2025 Q4	$23.1M	Hold	1,472,331	–	–	4.82%	3
2025 Q3	$10.9M	Hold	1,472,331	–	–	2.39%	5
2025 Q2	$6.64M	Hold	1,472,331	–	–	1.85%	4
2025 Q1	$6.83M	Hold	1,472,331	–	–	2.37%	5
2024 Q4	$10.2M	Hold	1,472,331	–	–	3.63%	4
2024 Q3	$7.8M	Hold	1,472,331	–	–	2.99%	6
2024 Q2	$5.51M	Hold	1,472,331	–	–	2.38%	7
2024 Q1	$10.4M	Hold	1,472,331	–	–	3.51%	6
2023 Q4	$8.32M	Hold	1,472,331	–	–	2.48%	6
2023 Q3	$7.05M	Hold	1,472,331	–	–	2.91%	6
2023 Q2	$10.1M	Hold	1,472,331	–	–	4.94%	5
2023 Q1	$11.5M	Hold	1,472,331	–	–	5.52%	5
2022 Q4	$11.2M	Hold	1,472,331	–	–	7.4%	4
2022 Q3	$12M	Hold	1,472,331	–	–	7.99%	4
2022 Q2	$14.2M	Hold	1,472,331	–	–	10.16%	3
2022 Q1	$20.6M	Hold	1,472,331	–	–	11.14%	2
2021 Q4	$30.1M	Hold	1,472,331	–	–	10.61%	2
2021 Q3	$32.8M	Hold	1,472,331	–	–	6.54%	2
2021 Q2	$33.4M	Buy	+1,472,331	New	+$30M	5.35%	3